These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 30661827)
61. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk]. Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287 [TBL] [Abstract][Full Text] [Related]
62. Physician practices regarding anticoagulation and cardioversion of atrial fibrillation. Schlicht JR; Davis RC; Naqi K; Cooper W; Rao BV Arch Intern Med; 1996 Feb; 156(3):290-4. PubMed ID: 8572839 [TBL] [Abstract][Full Text] [Related]
63. Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery. Schulman S; Cybulsky I; Delaney J Thromb Res; 2015 May; 135(5):841-5. PubMed ID: 25776468 [TBL] [Abstract][Full Text] [Related]
64. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies. Garwood CL; Hwang JM; Moser LR Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182 [TBL] [Abstract][Full Text] [Related]
65. Cardioversion of atrial arrhythmias: audit of anticoagulation management. Mayet J; Wasan B; Sutton GC J R Coll Physicians Lond; 1997; 31(3):313-6. PubMed ID: 9192336 [TBL] [Abstract][Full Text] [Related]
66. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol]. Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508 [TBL] [Abstract][Full Text] [Related]
67. [Anticoagulation in non-rheumatic atrial fibrillation. Recommendations based on five prospective studies]. Prohaska M; von Essen R Fortschr Med; 1994 Jan; 112(1-2):25-8. PubMed ID: 8144116 [TBL] [Abstract][Full Text] [Related]
68. Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami. Cerasuolo JO; Montero-Odasso M; Ibañez A; Doocy S; Lip GY; Sposato LA Int J Stroke; 2017 Apr; 12(3):222-228. PubMed ID: 28381196 [TBL] [Abstract][Full Text] [Related]
69. [Pre-interventional, peri-interventional and post-interventional anticoagulation in the setting of catheter ablation for atrial fibrillation : current practice and practical approach]. Antz M; Willems S; Hoffmann BA Herz; 2015 Feb; 40(1):45-9. PubMed ID: 25645235 [TBL] [Abstract][Full Text] [Related]
70. Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation. Schrickel JW; Linhart M; Bänsch D; Thomas D; Nickenig G Clin Res Cardiol; 2016 Feb; 105(2):95-105. PubMed ID: 26514352 [TBL] [Abstract][Full Text] [Related]
71. The search for atrial fibrillation and its impact on public health. Lam A; Goulouti E; Roten L Swiss Med Wkly; 2017; 147():w14447. PubMed ID: 28695554 [TBL] [Abstract][Full Text] [Related]
72. Atrial fibrillation. Ziv O; Choudhary G Prim Care; 2005 Dec; 32(4):1083-107. PubMed ID: 16326228 [TBL] [Abstract][Full Text] [Related]
73. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients]. Reicke B; Masuhr F; Weih M Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772 [TBL] [Abstract][Full Text] [Related]
74. Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis. Vazquez FJ; Gonzalez JP; Gándara E PLoS One; 2015; 10(11):e0142222. PubMed ID: 26561858 [TBL] [Abstract][Full Text] [Related]
75. Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study. Barrios V; Escobar C; Prieto L; Osorio G; Polo J; Lobos JM; Vargas D; García N Rev Esp Cardiol (Engl Ed); 2015 Sep; 68(9):769-76. PubMed ID: 26169326 [TBL] [Abstract][Full Text] [Related]
76. APOLLO I: Anticoagulation control in atrial fibrillation. Pinho-Costa L; Moreira S; Azevedo C; Azevedo P; Castro E; Sousa H; Melo M Rev Port Cardiol; 2015 May; 34(5):337-45. PubMed ID: 25935073 [TBL] [Abstract][Full Text] [Related]
77. Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management. Bahbahani H; AlTurki A; Dawas A; Lipman ML BMC Nephrol; 2018 Jan; 19(1):4. PubMed ID: 29310600 [TBL] [Abstract][Full Text] [Related]
78. Mortality of atrial fibrillation in a population selected to be free of major cardiovascular impairments. Iacovino JR J Insur Med; 1999; 31(1):8-12. PubMed ID: 10539392 [TBL] [Abstract][Full Text] [Related]
79. Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis. Garton AB; Dudzinski J; Kowey PR J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1411-8. PubMed ID: 25216104 [TBL] [Abstract][Full Text] [Related]
80. Reply: Can silent brain lesions be a target to guide anticoagulation treatment in patients with low-risk atrial fibrillation to reduce cognitive impairment? Gaita F; Corsinovi L; Anselmino M J Am Coll Cardiol; 2014 May; 63(20):2175. PubMed ID: 24613326 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]